• 200+

    The UK’s most active investor in UK university spinouts

  • £500M

    Over £500m raised; invested into over 200 companies

  • £160M

    Cash returned to investors via exits

  • £1B

    Part of FTSE 250 sector specialist group with £950m net assets

About Parkwalk

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.

Performance

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Learn More

Parkwalk Open Funds

Parkwalk offer early-stage investment funds, investing in high-growth, knowledge intensive companies spun out of the UK’s world-leading universities and providing tax benefits under the Enterprise Investment Scheme.

Opportunities EIS Fund

Our evergreen EIS Fund, investing in EIS-qualifying hard science and deep tech companies spun out of universities across the UK.
Learn More

Northern Universities Venture Fund

The Northern Universities Venture Fund, in collaboration with Northern Gritstone, offers investors access to businesses from the Northern Arc Universities of Leeds, Liverpool, Manchester and Sheffield.
Learn more

Meet the Parkwalk team

Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns.

Kathy Samii
Alastair Kilgour
Olivia Smith
Meet the team

Empowering Innovation

Parkwalk Funds invest in dynamic university spinout companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

Wave Photonics

Wave Photonics enable rapid photonic integrated circuit development for any wavelength or platform. The company help new photonics fabrication process

Hone Bio Limited (Cytoseek)

Hone Bio (previously Cytoseek) has developed a novel cell membrane augmentation technology, enabling the addition of new functionalities to cell thera

Enhanc3D Genomics

Enhanc3D Genomics is developing a proprietary technology that simultaneously profiles 3D genome folding at high resolution for all genes and their enh

View Portfolio

Contact Information

This field is for validation purposes and should be left unchanged.